Trending News

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel
Posted On Tuesday, April 29, 2025
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
Posted On Tuesday, April 29, 2025
Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting
Posted On Tuesday, April 29, 2025
Certara to Participate in Upcoming Investor Conferences
Posted On Tuesday, April 29, 2025
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
Posted On Tuesday, April 29, 2025
Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting
Posted On Tuesday, April 29, 2025
Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time
Posted On Tuesday, April 29, 2025
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
Posted On Tuesday, April 29, 2025
BridgeBio Reports First Quarter 2025 Financial Results and Business Updates
Posted On Tuesday, April 29, 2025
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
Posted On Tuesday, April 29, 2025
FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT
Posted On Tuesday, April 29, 2025
AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
Posted On Tuesday, April 29, 2025
Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025
Posted On Tuesday, April 29, 2025
Therini Bio Announces Positive Phase 1a Trial Results Evaluating THN391 for Neurodegenerative Diseases
Posted On Tuesday, April 29, 2025
ZBIO Investor Reminder: Cohen Milstein Encourages Zenas BioPharma Investors to Consider Leading Class Action Following IPO Stock Collapse
Posted On Tuesday, April 29, 2025
Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting
Posted On Tuesday, April 29, 2025
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
Posted On Tuesday, April 29, 2025
Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025
Posted On Tuesday, April 29, 2025
Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
Posted On Tuesday, April 29, 2025
Four-year Follow-up Data on SPRINT® PNS for Low Back Pain Highlights Sustained Pain Relief Avoiding Costly and Invasive Treatments
Posted On Tuesday, April 29, 2025
Digital Utilities Ventures Announces Planned Name Change and Corporate Move as Strategic Evolution Continues
Posted On Tuesday, April 29, 2025
Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer
Posted On Tuesday, April 29, 2025
CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025
Posted On Tuesday, April 29, 2025
Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025
Posted On Tuesday, April 29, 2025
CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany
Posted On Tuesday, April 29, 2025

Print